AstraZeneca said it would begin to earn a modest profit from its coronavirus vaccine as the world learns to live with the virus and the drugmaker is in talks with…
By Ludwig Burger GlaxoSmithKline said its anaemia pill for patients with kidney disease was shown to have about the same side effect risk as the current standard treatment in two…
By Carl O’Donnell An estimated 30 million to 50 million doses of Johnson & Johnson’s COVID-19 vaccine made early this year sits idle in Emergent BioSolutions Inc’s plant in Baltimore…
Across the developing world, hundreds of millions of people are unable to get a vaccine to protect themselves from the ravages of COVID-19, and millions of them have already become…
A new treatment could soon help protect people from developing severe COVID. AstraZeneca has just released results from a phase 3 clinical trial – the final stage of testing before…
India will soon have administered 1 billion Covid-19 vaccine doses, but the milestone masks a yawning gap between the number of people who have been fully inoculated and those that…
AstraZeneca India Private Limited announced the launch of a clinical data and insights division in the country to further strengthen its global presence and manage data-related aspects of its clinical…
WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech’s COVID-19 vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca…
London: People who had received a first dose of the Oxford-AstraZeneca Covid-19 vaccine and received an mRNA shot for their second dose had a lower risk of infection compared to…
Some of India’s private hospitals have cancelled orders for Russia’s Sputnik V vaccine as they struggle to sell COVID-19 shots amid surging supplies of free doses of other vaccines offered…
